4//SEC Filing
Zhan Hangjun 4
Accession 0001250853-21-000022
CIK 0001561743other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 8:50 PM ET
Size
10.1 KB
Accession
0001250853-21-000022
Insider Transaction Report
Form 4
Zhan Hangjun
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2021-01-23$4.93/sh−3,385$16,688→ 39,306 total - Tax Payment
Common Stock
2021-01-22$4.93/sh−3,385$16,688→ 42,691 total - Exercise/Conversion
Common Stock
2021-01-22+6,250→ 46,076 total - Exercise/Conversion
Restricted Stock Units
2021-01-22−6,250→ 6,250 total→ Common Stock (6,250 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]These shares are being surrendered to satisfy a tax withholding obligation of the reporting person.
- [F3]On January 22, 2018, the reporting person was granted 25,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
Documents
Issuer
Kindred Biosciences, Inc.
CIK 0001561743
Entity typeother
Related Parties
1- filerCIK 0001719057
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 8:50 PM ET
- Size
- 10.1 KB